Table 4. Independent predictors for lowest tertile of Apo B/A1 ratio decrease.
| Variable | Univariate analysis | Multivariate analysis | ||||
|---|---|---|---|---|---|---|
| OR | 95% CI | p-value | OR | 95% CI | p-value | |
| Age | 1.013 | 0.994–1.032 | 0.183 | 0.988 | 0.966–1.012 | 0.328 |
| Male | 0.705 | 0.457–1.085 | 0.112 | 0.676 | 0.395–1.157 | 0.153 |
| Diabetes | 1.167 | 0.787–1.729 | 0.442 | |||
| Hypertension | 1.819 | 1.125–2.724 | 0.004 | 1.531 | 0.959–2.444 | 0.075 |
| Smoking hx | 1.121 | 0.755–1.664 | 0.570 | |||
| BMI | 0.987 | 0.927–1.051 | 0.692 | |||
| Lowest tertile of LDL-C at index PCI | 7.982 | 5.113–12.461 | <0.001 | 9.132 | 5.659–14.738 | <0.001 |
| Non-high intensity statin at index PCI | 1.928 | 1.293–2.875 | 0.001 | 2.458 | 1.195–5.056 | 0.015 |
| Non-high intensity statin at lipid profile follow up | 1.532 | 1.021–2.297 | 0.039 | 0.928 | 0.446–1.929 | 0.840 |
| ACE inhibitor/ARB | 0.861 | 0.484–1.531 | 0.610 | |||
| Beta blocker | 0.758 | 0.436–1.319 | 0.327 | |||
| CCB | 1.175 | 0.681–2.026 | 0.562 | |||
ACE; angiotensin-converting enzyme, Apo A1; apolipoprotein A1, Apo B; apolipoprotein B, ARB; angiotensin receptor antagonist, BMI; body mass index, CCB; calcium channel blocker, CI; confidence interval, LDL-C; low-density lipoprotein cholesterol, OR; odds ratio, PCI; percutaneous coronary intervention.